申请人:Anandan K. Sampath
公开号:US20060199829A1
公开(公告)日:2006-09-07
Disclosed are compounds of formula I that inhibit histone deacetylase (HDAC) enzymatic activity, pharmaceutical compositions comprising such compounds, as well as methods to treat conditions, particularly proliferative conditions, mediated at least in part by HDAC, wherein A, W, W
1
, W
2
, Ar
2
, and G are described herein.
本发明涉及公式I的化合物,其抑制组蛋白去乙酰化酶(HDAC)酶活性,包括这样的化合物的制药组合物,以及用于治疗至少部分由HDAC介导的疾病,特别是增殖性疾病的方法,其中A,W,W1,W2,Ar2和G如本文所述。